New research suggests that just one or two individual herpes virus particles attack a skin cell in the first stage of an outbreak, resulting in a bottleneck in which the infection may be vulnerable to medical treatment.
Nov 5, 2012
1
0
(HealthDay)—A new vaccination approach may provide protection against genital herpes as well as other sexually transmitted infections, including HIV, according to a new study involving mice.
Oct 17, 2012
0
0
WHAT: Further analyses of the landmark NIH-funded treatment-as-prevention study (HPTN 052) have found that providing antiretroviral treatment to HIV-infected individuals earlier, when their immune systems are healthier, delays ...
Jul 27, 2012
0
0
(HealthDay) -- The practice of "oral-genital suction" performed during some Orthodox Jewish circumcision ceremonies could leave the infant with a potentially fatal herpes virus infection, health officials warn.
Jun 7, 2012
2
0
(Medical Xpress) -- Could engineered human stem cells hold the key to cancer survival? Scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research ...
Apr 20, 2012
0
0
A study combining three trials of antiviral therapy to treat genital herpes (herpes simplex virus type 2/HSV-2) has shown that the virus can reactivate in 'breakthrough episodes' even when doses of antiviral therapy are high. ...
Jan 4, 2012
0
0
An investigational vaccine protected some women against infection from one of the two types of herpes simplex viruses that cause genital herpes, according to findings in the New England Journal of Medicine.
Jan 4, 2012
0
0
A team of researchers from the University of Utah and the University of Massachusetts has identified the first gene associated with frequent herpes-related cold sores.
Nov 30, 2011
0
0
Investigators have identified a human chromosome containing a specific gene associated with susceptibility to herpes simplex labialis (HSL), the common cold sore. Published in the Journal of Infectious Diseases and now available ...
Oct 28, 2011
0
0
A University of Queensland (UQ) start-up company, Coridon Pty Ltd, established to commercialise Professor Ian Frazer's work in developing next generation DNA vaccines, has successfully completed pre-clinical efficacy testing ...
Oct 24, 2011
0
0
